NASDAQ · CVRX
CVRx, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CVRX: Nov 05, 2026
CVRx, Inc. Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 3 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.49. The reported EPS for the same quarter last year was $-0.49.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.49 | $-0.47 | $-0.53 | 3 |
| Dec 2026 | $-0.48 | $-0.46 | $-0.49 | 3 |
| Mar 2027 | $-0.50 | $-0.47 | $-0.53 | 2 |
| Jun 2027 | $-0.49 | $-0.45 | $-0.53 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · The Motley Fool · MarketBeat- RTTNews · Sep 21, 4:52 PM EDTCVRx Appoints As John Landry CFO(RTTNews) – On Monday, CVRx, Inc. (CVRX), a commercial-stage medical device company, announced the appointment of John Landry as the Chief Financial Officer, effective October 12. He succeeds John Oasheim, who will remain with the Company for a transition period consistent with h
- Zacks · Sep 17, 6:21 AM EDTBeta Bionics, Inc. (BBNX) Surges 15.3%: Is This an Indication of Further Gains?Beta Bionics, Inc. (BBNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- The Motley Fool · Aug 31, 5:04 AM EDTJohnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.J&J's portfolio primarily includes small biotech and medtech companies.
- Zacks · Aug 28, 11:39 AM EDTCVRx Secures Devoted Health Coverage for Barostim TherapyCVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.
- The Motley Fool · Aug 13, 6:15 PM EDTCVRx (CVRX) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 13, 3:02 AM EDTCVRx Eyes Barostim Growth as Coverage Gains and BENEFIT-HF Trial LaunchesCVRx (NASDAQ:CVRX) outlined its efforts to expand adoption of its Barostim therapy for heart failure patients, emphasizing sales-force execution, payer coverage progress and a large post-market clinical trial during Canaccord Genuity’s 46th Annual Growth Conference. President an
- RTTNews · Aug 7, 3:21 AM EDTCVRx Reports Q2 2026 Results, Shows Revenue Growth But Maintains Net Loss(RTTNews) – CVRx, Inc. (CVRX), a commercial-stage medical device company focused on neuromodulation solutions for cardiovascular disease, announced financial results for the second quarter of 2026.
- Zacks · Aug 6, 10:35 PM EDTCVRx (CVRX) Reports Q2 Loss, Beats Revenue EstimatesCVRx (CVRX) delivered earnings and revenue surprises of -1.92% and +0.40%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- MarketBeat · Aug 6, 9:03 PM EDTCVRx Q2 Earnings Call HighlightsCVRx (NASDAQ:CVRX) reported second-quarter revenue growth and an improved gross margin, but lowered its full-year outlook as sales-force turnover, slower productivity ramps and reimbursement challenges with a large Medicare Advantage payer are expected to weigh on results in the
- Zacks · Aug 6, 8:00 PM EDTCompared to Estimates, CVRx (CVRX) Q2 Earnings: A Look at Key MetricsWhile the top- and bottom-line numbers for CVRx (CVRX) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- Zacks · Aug 5, 6:10 PM EDTPacific Biosciences of California (PACB) Reports Q2 Loss, Lags Revenue EstimatesPacific Biosciences (PACB) delivered earnings and revenue surprises of 0.00% and -4.16%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jun 29, 6:44 AM EDTCVRx (CVRX) Moves 11.6% Higher: Will This Strength Last?CVRx (CVRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for CVRx, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.